VVOS · Vivos Therapeutics Inc
United States · RS rating 4 · As of 2026-11-03
| Price | 0.11 USD |
|---|---|
| 1-day change | +1.7% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 13 / 4 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 5 / 23 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +10.9% |
| Sales growth Q/Q | +77.6% |
| Distance from 52-week high | +95.8% |
| Market cap (USD) | $12.1M |